Olicard Retard (Isosorbide Mononitrate)

Isosorbide Mononitrate, the active ingredient in Olicard Retard, is a nitrate presented as a prolonged‑release oral tablet for once‑daily use. It helps manage chronic stable angina by reducing the heart’s oxygen demand in adult patients. GNH USA supplies Olicard Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olicard Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olicard Retard, a nitrate class medication, is employed in the management of several cardiovascular conditions.

- Chronic stable angina: Improves exercise tolerance and reduces frequency of angina attacks. - Heart failure with preserved ejection fraction: May alleviate symptoms related to myocardial oxygen imbalance. - Prophylaxis of angina pectoris: Prevents episodes of chest pain during physical exertion.

Adverse reactions to isosorbide mononitrate vary in frequency and severity.

Common Side Effects: - Headache: Often transient and may lessen with continued therapy. - Flushing: Warm sensation, typically mild. - Dizziness or light‑headedness: Related to blood‑pressure reduction. - Nausea: Mild gastrointestinal upset. - Fatigue: General tiredness without exertion. - Palpitations: Sensation of irregular heartbeat.

Serious or Rare Side Effects: - Severe hypotension: Marked drop in blood pressure causing fainting. - Methemoglobinemia: Unusual discoloration of skin and mucous membranes. - Allergic reactions: Rash, itching, swelling, or anaphylaxis. - Syncope: Sudden loss of consciousness. - Chest pain worsening: Paradoxical increase in angina. - Renal impairment exacerbation: Decline in kidney function in susceptible patients.

When prescribing Olicard Retard, clinicians should consider several safety measures.

- Cardiovascular assessment: Evaluate blood pressure and heart rate before initiation. - Concomitant nitrates: Avoid combined use to prevent severe hypotension. - Phosphodiesterase‑5 inhibitors: Do not co‑administer due to risk of profound vasodilation. - Hepatic impairment: Use cautiously; dose adjustment may be required. - Elderly patients: Monitor for dizziness and falls. - Store at ambient temperature: Keep below 25°C in the original container, protected from moisture.

Isosorbide mononitrate interacts with several drug classes that can modify its hemodynamic effects.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): May cause additive hypotensive effects. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): Heightened risk of severe blood‑pressure fall. - Antihypertensive agents: Combined therapy can lead to excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely): - Diuretics: May amplify orthostatic hypotension. - Alcohol: Can increase vasodilatory response and dizziness. - Certain antibiotics (e.g., macrolides): May affect metabolism and plasma levels.